Skip to content
NBDC Human Database

No datasets in the cart.

Go to the cart

Due to system maintenance, the application system, application review by the Data Access Committee will be unavailable during the following period.
Schedule: October 5th (Mon), 2026, 9:00 - October 7th (Wed), 2026, 15:00 (JST)
We apologize for any inconvenience this may cause and appreciate your understanding.

We are currently receiving a large number of applications for data submission, and the review process is taking longer than usual.We sincerely apologize for the delay and kindly ask for your understanding. When submitting an application, we would greatly appreciate it if you could allow sufficient time for the processing.

Following a change to our organizational structure effective April 1, 2026, this division has been renamed from the "Database Center for Life Science, Joint Support-Center for Data Science Research" to the "Database Division for Life Science (DBCLS), BioData Science Initiative (BSI), National Institute of Genetics (NIG)". Where the former name still appears in the guidelines, please read it as the new name.

Dataset ID

JGAD000977

Type of data
NGS (RNA-seq, ATAC-seq, scMultiome)
Access criteria
Controlled-access (Type I)
Total data volume
583 GB
File formats
  • FASTQ
Research
hum0225
Date published
2025-09-24
Date modified
2025-09-24
DDBJ Search
JGAD000977 (opens in a new tab)
JGA Study
JGAS000835 (opens in a new tab)

Analysis method

RNA-seq

Materials and participants
HAM (ICD-10: A858/B973): 13 cases
  • Health status
    Affected
  • Subject count
    13 (Individual)
Disease
HAM (A858, B973)
Sample description
RNAs extracted from HTLV-1-infected T cells sorted using anti-CD4, anti-CADM1, and anti-CD7 antibodies
  • Tissue
    Peripheral blood
  • Tumor / normal
    Normal
Sample provider
N/A
Experimental method
RNA-seq
Target
N/A
Reagent kit
NEBNext rRNA Depletion Kit
Fragmentation
chemical fragmentation
Platform
Illumina NovaSeq 6000
Read type
Paired-end
Read length
300 bp
Data use policy
NBDC data sharing policy (JGAP000001)

ATAC-seq

Materials and participants
HAM (ICD-10: A858/B973): 2 cases
  • Health status
    Affected
  • Subject count
    2 (Individual)
Disease
HAM (A858, B973)
Sample description
DNAs extracted from HTLV-1-infected T cells sorted using anti-CD4, anti-CADM1, and anti-CD7 antibodies
  • Tissue
    Peripheral blood
  • Tumor / normal
    Normal
Sample provider
N/A
Experimental method
ATAC-seq
Target
N/A
Fragmentation
Ultrasonic fragmentation (Covaris)
Platform
Illumina NovaSeq 6000
Read type
Paired-end
Read length
300 bp
Data use policy
NBDC data sharing policy (JGAP000001)

scRNA-seq + scATAC-seq

Materials and participants
HAM (ICD-10: A858/B973): 2 cases
HTLV-1-infected asymptomatic individuals: 3 cases
  • Health status
    Mixed
  • Subject count
    5 (Individual)
Disease
HAM (A858, B973)
HTLV-1-infected asymptomatic individuals (A858, B973)
Sample description
DNAs/RNAs extracted from peripheral blood mononuclear cells
  • Tissue
    PBMC, Peripheral blood
  • Tumor / normal
    Mixed
Sample provider
N/A
Experimental method
scATAC-seq
scRNA-seq
Target
N/A
Reagent kit
Chromium Next GEM Single Cell Multiome ATAC + Gene Expression
Fragmentation
Enzymatic fragmentation
Platform
Illumina NovaSeq 6000
Read type
Paired-end
Read length
scRNA-seq: 118 bp
scATAC-seq: 99 bp
Data use policy
NBDC data sharing policy (JGAP000001)